Literature DB >> 2126099

Development of a new in vivo model for head and neck cancer.

A Dinesman1, B Haughey, G A Gates, T Aufdemorte, D D Von Hoff.   

Abstract

We have developed an improved model for studying in vivo nonsurgical treatment of head and neck cancer. In situ oral cavity implantation has been documented, but its natural history is not defined. In light of this, an improved model is described. Forty-two nude mice had tumor cells from one of two established laryngeal squamous cell carcinoma cell lines implanted into the floor of the mouth. The tumor mass was measured and followed. When the tumor burden was great enough to cause cachexia, the animals were killed and submitted for microscopic examination. Pulmonary metastases were noted in 44%, bone invasion in 80%, angioinvasion in 76%, and soft tissue invasion in 96% of the animals. Growth characteristics in the head and neck have not been documented in previous models. Our model not only exhibits the locally invasive activity typically associated with malignant neoplasms, but also closely parallels the results of clinical studies examining the percent of end stage patients and autopsies with pulmonary metastases. Therefore, this model should open the way for more meaningful in vivo studies of nonsurgical treatment modalities for both local and metastatic tumor foci in head and neck cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2126099     DOI: 10.1177/019459989010300517

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  14 in total

1.  Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).

Authors:  Nadarajah Vigneswaran; Jean Wu; Anren Song; Ananth Annapragada; Wolfgang Zacharias
Journal:  Exp Mol Pathol       Date:  2011-01-12       Impact factor: 3.362

2.  Immunotherapy in new pre-clinical models of HPV-associated oral cancers.

Authors:  Francesca Paolini; Silvia Massa; Isabella Manni; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 3.  Reviewing and reconsidering invasion assays in head and neck cancer.

Authors:  Ronald C Inglehart; Christina S Scanlon; Nisha J D'Silva
Journal:  Oral Oncol       Date:  2014-10-14       Impact factor: 5.337

4.  Animal models of cancer in the head and neck region.

Authors:  Seungwon Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-06-27       Impact factor: 3.372

5.  Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens.

Authors:  X Y Fu; J M Besterman; A Monosov; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

Review 7.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 8.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

Review 9.  Xenograft models of head and neck cancers.

Authors:  Daisuke Sano; Jeffrey N Myers
Journal:  Head Neck Oncol       Date:  2009-08-13

10.  Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.

Authors:  M Gerretsen; G W Visser; R H Brakenhoff; M van Walsum; G B Snow; G A van Dongen
Journal:  Cell Biophys       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.